135 related articles for article (PubMed ID: 36447407)
1.
Pauletto P; Bortoli M; Bright FO; Delgado CP; Nogara PA; Orian L; da Rocha JBT
J Biomol Struct Dyn; 2023 Nov; 41(19):9562-9575. PubMed ID: 36447407
[TBL] [Abstract][Full Text] [Related]
2. Acid sphingomyelinase (ASM) and COVID-19: A review of the potential use of ASM inhibitors against SARS-CoV-2.
Pauletto PJT; Delgado CP; da Rocha JBT
Cell Biochem Funct; 2023 Apr; 41(3):284-295. PubMed ID: 36929117
[TBL] [Abstract][Full Text] [Related]
3. The acid sphingomyelinase/ceramide system in COVID-19.
Kornhuber J; Hoertel N; Gulbins E
Mol Psychiatry; 2022 Jan; 27(1):307-314. PubMed ID: 34608263
[TBL] [Abstract][Full Text] [Related]
4. Structure of Human Acid Sphingomyelinase Reveals the Role of the Saposin Domain in Activating Substrate Hydrolysis.
Xiong ZJ; Huang J; Poda G; Pomès R; Privé GG
J Mol Biol; 2016 Jul; 428(15):3026-42. PubMed ID: 27349982
[TBL] [Abstract][Full Text] [Related]
5.
Tronco Pauletto PJ; Omage FB; Delgado CP; Nogara PA; Teixeira Rocha JB
Curr Drug Discov Technol; 2023; 20(2):e101022209771. PubMed ID: 36221883
[TBL] [Abstract][Full Text] [Related]
6. Derivatization of common antidepressant drugs increases inhibition of acid sphingomyelinase and reduces induction of phospholipidosis.
Rhein C; Löber S; Gmeiner P; Gulbins E; Tripal P; Kornhuber J
J Neural Transm (Vienna); 2018 Dec; 125(12):1837-1845. PubMed ID: 30191367
[TBL] [Abstract][Full Text] [Related]
7. Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies.
Abusukhun M; Winkler MS; Pöhlmann S; Moerer O; Meissner K; Tampe B; Hofmann-Winkler H; Bauer M; Gräler MH; Claus RA
Front Immunol; 2021; 12():784989. PubMed ID: 34987511
[TBL] [Abstract][Full Text] [Related]
8. An Early-Onset Neuronopathic Form of Acid Sphingomyelinase Deficiency: A SMPD1 p.C133Y Mutation in the Saposin Domain of Acid Sphingomyelinase.
Ota S; Noguchi A; Kondo D; Nakajima Y; Ito T; Arai H; Takahashi T
Tohoku J Exp Med; 2020 Jan; 250(1):5-11. PubMed ID: 31941852
[TBL] [Abstract][Full Text] [Related]
9. Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity.
Alkafaas SS; Abdallah AM; Hassan MH; Hussien AM; Elkafas SS; Loutfy SA; Mikhail A; Murad OG; Elsalahaty MI; Hessien M; Elshazli RM; Alsaeed FA; Ahmed AE; Kamal HK; Hafez W; El-Saadony MT; El-Tarabily KA; Ghosh S
BMC Public Health; 2024 Feb; 24(1):395. PubMed ID: 38321448
[TBL] [Abstract][Full Text] [Related]
10. Repurposing FIASMAs against Acid Sphingomyelinase for COVID-19: A Computational Molecular Docking and Dynamic Simulation Approach.
Naz A; Asif S; Alwutayd KM; Sarfaraz S; Abbasi SW; Abbasi A; Alenazi AM; Hasan ME
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049752
[TBL] [Abstract][Full Text] [Related]
11. Acid sphingomyelinase deactivation post-ischemia promotes brain angiogenesis and remodeling by small extracellular vesicles.
Mohamud Yusuf A; Hagemann N; Zhang X; Zafar M; Hussner T; Bromkamp C; Martiny C; Tertel T; Börger V; Schumacher F; Solari FA; Hasenberg M; Kleinschnitz C; Doeppner TR; Kleuser B; Sickmann A; Gunzer M; Giebel B; Kolesnick R; Gulbins E; Hermann DM
Basic Res Cardiol; 2022 Dec; 117(1):43. PubMed ID: 36038749
[TBL] [Abstract][Full Text] [Related]
12. Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism.
Breiden B; Sandhoff K
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445706
[TBL] [Abstract][Full Text] [Related]
13. Solving the secretory acid sphingomyelinase puzzle: Insights from lysosome-mediated parasite invasion and plasma membrane repair.
Andrews NW
Cell Microbiol; 2019 Nov; 21(11):e13065. PubMed ID: 31155842
[TBL] [Abstract][Full Text] [Related]
14. Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs.
Gulbins E; Palmada M; Reichel M; Lüth A; Böhmer C; Amato D; Müller CP; Tischbirek CH; Groemer TW; Tabatabai G; Becker KA; Tripal P; Staedtler S; Ackermann TF; van Brederode J; Alzheimer C; Weller M; Lang UE; Kleuser B; Grassmé H; Kornhuber J
Nat Med; 2013 Jul; 19(7):934-8. PubMed ID: 23770692
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal ceramide generated by acid sphingomyelinase triggers cytosolic cathepsin B-mediated degradation of X-linked inhibitor of apoptosis protein in natural killer/T lymphoma cell apoptosis.
Taniguchi M; Ogiso H; Takeuchi T; Kitatani K; Umehara H; Okazaki T
Cell Death Dis; 2015 Apr; 6(4):e1717. PubMed ID: 25855965
[TBL] [Abstract][Full Text] [Related]
16. Trypanosoma cruzi subverts the sphingomyelinase-mediated plasma membrane repair pathway for cell invasion.
Fernandes MC; Cortez M; Flannery AR; Tam C; Mortara RA; Andrews NW
J Exp Med; 2011 May; 208(5):909-21. PubMed ID: 21536739
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine.
Brunkhorst R; Friedlaender F; Ferreirós N; Schwalm S; Koch A; Grammatikos G; Toennes S; Foerch C; Pfeilschifter J; Pfeilschifter W
Neural Plast; 2015; 2015():503079. PubMed ID: 26605090
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells.
Carpinteiro A; Edwards MJ; Hoffmann M; Kochs G; Gripp B; Weigang S; Adams C; Carpinteiro E; Gulbins A; Keitsch S; Sehl C; Soddemann M; Wilker B; Kamler M; Bertsch T; Lang KS; Patel S; Wilson GC; Walter S; Hengel H; Pöhlmann S; Lang PA; Kornhuber J; Becker KA; Ahmad SA; Fassbender K; Gulbins E
Cell Rep Med; 2020 Nov; 1(8):100142. PubMed ID: 33163980
[TBL] [Abstract][Full Text] [Related]
19. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine.
Schloer S; Brunotte L; Goretzko J; Mecate-Zambrano A; Korthals N; Gerke V; Ludwig S; Rescher U
Emerg Microbes Infect; 2020 Dec; 9(1):2245-2255. PubMed ID: 32975484
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells.
Carpinteiro A; Gripp B; Hoffmann M; Pöhlmann S; Hoertel N; Edwards MJ; Kamler M; Kornhuber J; Becker KA; Gulbins E
J Biol Chem; 2021; 296():100701. PubMed ID: 33895135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
